Fourteen years ago Dr Matthew Watson, a burly, bearded volcanologist at the University of Bristol, was leading a project that ...
Veradermics, Incorporated’s VDPHL01 hair-loss drug shows promising data, targets a large cash-pay market, and is funded into ...